Skip to main content
SpringerLink
Log in

Predicted and actual BCNU concentrations in normal rabbit brain during intraarterial and intravenous infusions

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Normal New Zealand White rabbits were used to compare theoretical brain concentrations (based upon pharmacokinetic modeling) with actual experimental concentrations of BCNU following intraarterial (IA) or intravenous (IV) infusions. IA infusion therapy for brain tumor patients has been promising based upon theoretical predictions but of limited effectiveness clinically. Experimentally-measured rabbit carotid artery flow rates (63.9 ± 3.4 ml/min) [mean ± 1 sem] and BCNU systemic clearances (197 ± 10.2 ml/min) predicted a theoretical IA advantage of 4.1 ± 0.2. lpsilateral brain concentrations of BCNU during and after IA infusions (20 mg/min/m2 over 15 minutes) were: 16.2 ± 2.9, 19.0 ± 3.9, 20.3 ± 2.8, 4.8 ± 2.5, 2.1 ± 1.5, and 1.7 ± 1.6 μg/gm brain at 5, 10, 15, 25, 35, and 45 minutes after infusion start. Mean concentrations at same time points in contralateral hemisphere (IA infusions) were: 7.1 ± 1.8, 9.0 ± 1.8, 10.3 ± 0.7, 4.2 ± 1.4, 2.2 ± 1.2, 2.0 ± 1.5 μg/gm brain. Concentrations in either hemisphere during IV infusions were similar to contralateral hemisphere during IA infusions. Comparison of ipsilateral: contralateral hemisphere ratios during and after IA infusions were: 3.2 ± 0.4, 2.6 ± 0.3, 2.2 ± 0.3, 1.1 ± 0.3, 1.0 ± 0.4, and 0.9 ± 0.3 at the same time points. Although these data show higher drug concentrations with IA infusions, actual values were considerably less than predicted by theoretical modeling. This discrepancy between theoretical and experimental results emphasizes need for further study of causes and remedies so that IA therapy can achieve better drug concentrations with less toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chen HSG, Gross JF: Intra-arterial infusion of anticancer drugs. Theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 64: 31–40, 1980

    Google Scholar 

  2. Collins JM: Pharmacologic rationale for regional drug delivery. J Clin Oncol 2: 498–504, 1984

    Google Scholar 

  3. Cowles AL, Fenstermacher JD: Theoretical considerations in the chemotherapy of brain tumors. In: Farah A, Welch AD (eds) Handbook of Experimental Pharmacology. Springer-Verlag, New York, 1974, pp 319–329

    Google Scholar 

  4. Foo SH, Ransohoff J, Berenstein A, Choy I: Intra-arterial BCNU chemotherapy for malignant gliomas. J Neurosurg 62: 458–459, 1985

    Google Scholar 

  5. Greenberg HS, Ensminger WD, Chandler WF, Layton PB, Junck L, Knake J, Vine AK: Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg 61: 423–429, 1984

    Google Scholar 

  6. Hochberg FH, Pruitt AA, Davis K, DeBruyn G: Intra-arterial BCNU chemotherapy of glioblastoma. Neurology 33 [Suppl 2]: 109, 1983

    Google Scholar 

  7. Iwadate Y, Namba H, Saegusa T, Sueyoshi K: Intra-arterial ACNU, CDDP chemotherapy for brain metastases from lung cancer: Comparison of cases with and without intraarterial mannitol infusion. No Shinkei Geka 21: 513–518, 1993

    Google Scholar 

  8. Johnson DW, Parkinson D, Wolpert SM, Kasdon DL, Kwan ES, Laucella M, Anderson ML: Intracarotid chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma. Neurosurgery 20: 577–583, 1987

    Google Scholar 

  9. Watne K, Hannisdal E, Nome O, Hager B, Hirschberg H: Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy. Acta Oncol 32: 307–310, 1993

    Google Scholar 

  10. Watne K, Hannisdal E, Nome O, Hager B, Wester K, Heier M, Hirschberg H: Combined intra-arterial chemotherapy followed by radiation in astrocytomas. J Neuro-Oncol 14: 73–80, 1992

    Google Scholar 

  11. West CR, Avellanosa AM, Barua NR, Patel A, Hong CI: Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and systemic chemotherapy for malignant gliomas. A follow-up study. Neurosurgery 13: 420–426, 1983

    Google Scholar 

  12. Greenberg HS, Ensminger WD, Layton PB, Gebarski S, Meyer M, Chafee B, Bender JF, Grillo-Lopez AJ: Phase I–II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas. Cancer Treat Rep 70: 353–357, 1986

    Google Scholar 

  13. Newton HB, Bromberg J, Junck L, Page MA, Greenberg HS: Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas. J Neuro-Oncol 15: 257–263, 1993

    Google Scholar 

  14. Papavero L, Loew F, Jaksche H: Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations. Acta Neurochir 85: 128–137, 1987

    Google Scholar 

  15. Shapiro WR, Green SB: Reevaluating the efficacy of intraarterial BCNU [letter]. J Neurosurg 66: 313–315, 1987

    Google Scholar 

  16. Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, Mealey J Jr, Ransohoff J, Mahaley MS Jr: A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76: 772–781, 1992

    Google Scholar 

  17. Stewart DJ, Grahovac Z, Hugenholtz H, DaSilva V, Richard MT, Benoit B, Belanger G, Russell N: Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosinearabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors. J Neuro-Oncol 17: 71–79, 1993

    Google Scholar 

  18. Defer G, Fauchon F, Schaison M, Chiras J, Brunet P: Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas. A prospective study with statistical analysis. Neuroradiology 33: 432–437, 1991

    Google Scholar 

  19. Kapp JP, Sanford RA: Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) leukoencephalopathy). An analysis of risk factors. J Neurosurg 19: 779–783, 1986

    Google Scholar 

  20. Kleinschmidt-DeMasters BK: Intracarotid BCNU leukoencephalopathy. Cancer 57: 1276–1280, 1986

    Google Scholar 

  21. Kupersmith MJ, Seiple WH, Holopigian K, Noble K, Hiesiger E, Warren F: Maculopathy caused by intra-arterially administered cisplatin and intravenously administered carmustine. Am J Ophthalmol 113: 435–438, 1992

    Google Scholar 

  22. Rigal-Sastourne JC, Bidaux F, Mir F, Crepy P, Lucas B, Renard JP, Derosier C, Maurin JF, Bourgeois H: Ocular complications of intracarotid chemotherapies with nitrosourea agents. J Fr Ophthalmol 16: 304–310, 1993

    Google Scholar 

  23. Daniels PM, Dawes DK, Prichard MML: Studies of the carotid rete and its associated arteries. Philos Trans R Soc Lond [Biol] 237: 173–216, 1953

    Google Scholar 

  24. Jeppsson PG, Olin T: Cerebral angiography in the rabbit. Lunds Universitets Arsskrift 56: 1–56, 1960

    Google Scholar 

  25. Spector WS: Surface area calculations. In: Spector WS (ed.) Handbook of Biological Data. WB Saunders, Philadelphia, 1956, p 175

    Google Scholar 

  26. Loo TL, Dion RL: Colorimetric method for the determination of 1,3-bis(2-chloroethyl)-1-nitrosourea. J Pharm Sci 54: 809–810, 1965

    Google Scholar 

  27. Smith RG, Blackstock SC, Cheung LK, Loo TL: Analysis for nitrosourea antitumor agents by gas chromatography-mass spectrometry. Anal Chem 53: 1205–1208, 1981

    Google Scholar 

  28. Perese DM, Day CE, Chardack WM: Chemotherapy of brain tumors by intra-arterial infusions. J Neurosurg 19: 215–219, 1962

    Google Scholar 

  29. Wilson CB: Chemotherapy of brain tumors by continuous arterial infusion. Surgery 55: 640–653, 1964

    Google Scholar 

  30. Oldfield EH, Dedrick RL, Chatterji DC, Yeager RL, Girton ME, Kornblith PL, Doppman JL: Arterial drug infusion with extracorporeal removal. II. Internal carotid carmustine in the Rhesus monkey. Cancer Treat Rep 69: 293–303, 1985

    Google Scholar 

  31. Omojola MF, Fox AJ, Auer RN, Vinuela FV: Hemorrhagic encephalitis produced by selective non-occlusive intracarotid BCNU injection in dogs. J Neurosurg 57: 791–796, 1982

    Google Scholar 

  32. Nagahiro S, Yamamoto YL, Diksic M, Mitsuka S, Sugimoto S, Feindel W. Neurotoxicity after intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea administration in the rat: Hemodynamic changes studied by double-tracer autoradiography. Neurosurgery 29: 19–26, 1991

    Google Scholar 

  33. Torn JC, Roosen K, Schachenmayr W: Brain necrosis after intraarterial chemotherapy and irradiation of malignant gliomas — A complication of both ACNU and BCNU? J Neuro-Oncol 11: 241–242, 1991

    Google Scholar 

  34. Kosuda S, Kusano S, Aoki S, Suzuki K, Fujii H, Kawakami R, Mezaki T, Akita S, Nakamura O, Shidara N: Brain SPECT by intraarterial infusion of 99mTc-HMPAO for assessing the cerebral distribution of carotid artery infusions in patients with brain tumor. Kaku Igaku 30: 613–620, 1993

    Google Scholar 

  35. Saris SC, Blasberg RG, Carson RE, deVroom HL, Lutz R, Dedrick RL, Pettigrew K, Chang R, Doppman J, Wright DC: Intravascular streaming during carotid artery infusions. Demonstration in humans and reduction using diastolephased pulsatile administration. J Neurosurg 74: 763–772, 1991

    Google Scholar 

  36. Bobo H, Kapp JP, Vance R: Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: Proposal of a new method of intra-arterial dosage calculation. J Neuro-Oncol 13: 291–299, 1992

    Google Scholar 

  37. Bradac GB, Soffietti R, Riva A, Stura G, Sales S, Schiffer D: Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas. Neuroradiology 34: 73–76, 1992

    Google Scholar 

  38. Junck L, Koeppe RA, Greenberg HS: Mixing in the human carotid artery during carotid drug infusion studied with PET. J Cereb Blood Flow Metab 9: 681–689, 1989

    Google Scholar 

  39. Levin VA, Kabra PM, Freeman-Dove MA: Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkey. J Neurosurg 48: 587–593, 1978

    Google Scholar 

  40. Welch KM, Spra PJ, Knowles L, Lance JW: Effect of prostaglandins on the internal and external carotid blood flow in the monkey. Possible relevance to cranial flow changes during migraine headaches. Neurology 24: 705–710, 1974

    Google Scholar 

  41. Egorin MJ, Bellis EH, Salcman M, Collins JM, Spiegel JF, Bachur NR: The pharmacology of diaziquone given in intravenous or intracarotid infusion to normal and intracranial tumor-bearing puppies. J Neurosurg 60: 1005–1013, 1984

    Google Scholar 

  42. Nakagawa H, Fujita T, Izumoto S, Kubo S, Nakajima Y, Turuzono K: Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration. Gan To Kagaku Ryoho18: 103–109, 1991

    Google Scholar 

  43. Feun LG, Savaraj N, Lee YY, Landy H, Martinez-Prieto J, Charnsangavej C, Post JD, Lee KF, Wallace S, Bowen B: A pilot clinical and pharmacokinetic study of intracarotid cisplatin and bleomycin. Selective Cancer Therapeutics 7: 29–36, 1991

    Google Scholar 

  44. Diksic M, Sako K, Feindel W, Kato A, Yamamoto L, Farrokhzad S, Thompson C: Pharmacokinetics of positron-labeled 1,3-bis(2-chloroethyl)nitrosourea in human brain tumors using positron emission tomography. Cancer Res 44: 3120–3124, 1984

    Google Scholar 

  45. Yamamoto YL, Diksic M, Sako K, Arita N, Feindel W, Thompson CJ: Pharmacokinetic and metabolic studies in human malignant glioma. In: Magistretti PL (ed.) Functional Radionuclide Imaging of the Brain. Raven Press, New York, 1983, pp 327–335

    Google Scholar 

  46. Hiesiger EM, Basler GA, Lipschutz L, Shapiro WR: Quantitative autoradiographic (QAR) determination of 14C-PCNU concentration [14C-PCNU] in C6 rat glioma after intracarotid (IC) administration. Proc Amer Assoc Cancer Res 26: 349, 1985

    Google Scholar 

  47. Levin VA, Hoffman W, Weinham RJ: Pharmacokinetics of BCNU in man. A preliminary study of 20 patients. Cancer Treat Rep 62: 1305–1312, 1978

    Google Scholar 

  48. Oldfield EH, Dedrick RL, Yeager RL, Clark WC, DeVroom HL, Chatterji DC, Doppman JL: Reduced systemic drug exposure to combining intra-arterial chemotherapy with hemoperfusion of regional venous drainage. J Neurosurg 63: 726–732, 1985

    Google Scholar 

  49. Uematsu S, Yang A, Kouba R: Normal and abnormal common carotid artery blood flow by transcutaneous ultrasonic volume flow meter. In: Dietrich EG (ed.) Non-invasive Assessment of the Cardiovascular System. PSG Inc., Littleton, Mass, 1982, pp 87–96

    Google Scholar 

  50. Tonn JC, Schönmayr R, Rap ZM, Schachenmayr W: Autoptic findings after regional ACNU therapy and irradiation in malignant gliomas. Reg Cancer Treat 2: 215–222, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, University of Texas, Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, Texas

    Samuel J. Hassenbusch

  2. Radiology Research Center, Johns Hopkins University School of Medicine, 21205, Baltimore, Maryland

    James H. Anderson

  3. Department of Oncology, John Hopkins University School of Medicine, 21205, Baltimore, Maryland, USA

    O. Michael Colvin

Authors
  1. Samuel J. Hassenbusch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James H. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Michael Colvin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hassenbusch, S.J., Anderson, J.H. & Colvin, O.M. Predicted and actual BCNU concentrations in normal rabbit brain during intraarterial and intravenous infusions. J Neuro-Oncol 30, 7–18 (1996). https://doi.org/10.1007/BF00177438

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00177438

Key words

Search

Navigation